US Stock MarketDetailed Quotes

Day One Biopharmaceuticals (DAWN)

Watchlist

21.435
-0.025-0.12%

Trading Apr 8 13:20 ET

2.21BMarket Cap-20.61P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Day One Biopharmaceuticals (DAWN) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-32.83%-103.76M

52.85%-14.15M

-111.44%-5.81M

49.51%-24.81M

-18.64%-59M

46.81%-78.11M

27.47%-30.01M

236.93%50.75M

-15.78%-49.13M

-91.38%-49.73M

Net income from continuing operations

-12.38%-107.32M

67.62%-21.28M

-153.26%-19.73M

-588.04%-30.32M

42.33%-36M

49.45%-95.5M

-20.55%-65.71M

180.25%37.04M

90.39%-4.41M

-47.22%-62.41M

Operating gains losses

100.07%71K

--0

----

---108M

--0

----

Depreciation and amortization

86.59%3.79M

30.96%994K

25.20%934K

136.27%964K

670.69%894K

429.77%2.03M

636.89%759K

653.54%746K

343.48%408K

30.34%116K

Other non cash items

----

1,733.33%55M

--0

----

Change In working capital

-209.30%-28.94M

-106.43%-1.72M

114.46%7.55M

-104.46%-2.27M

-2,775.39%-32.51M

181.16%26.48M

603.37%26.74M

-5,254.56%-52.21M

5,872.13%50.74M

-83.74%1.22M

-Change in receivables

7.33%-12.86M

-93.75%-10.04M

573.92%2.97M

82.32%-1.62M

---4.18M

---13.88M

---5.18M

--441K

---9.14M

--0

-Change in inventory

11.81%-2.86M

237.86%772K

81.21%-480K

-2,179.07%-2.94M

---212K

---3.24M

---560K

---2.55M

---129K

--0

-Change in prepaid assets

153.15%2.37M

269.87%3.8M

-53.99%346K

72.34%-1.07M

-179.19%-700K

-45.52%-4.46M

-93.42%-2.23M

191.15%752K

-56.80%-3.87M

-35.85%884K

-Change in payables and accrued expense

-136.32%-15.54M

-87.06%4.36M

108.62%4.77M

-95.25%3.04M

-6,411.16%-27.71M

231.94%42.79M

565.37%33.68M

-120,139.13%-55.31M

3,696.85%63.98M

-92.91%439K

-Change in other current liabilities

-163.32%-309K

-149.28%-377K

-86.44%-110K

179.09%87K

184.26%91K

220.49%488K

821.70%765K

43.27%-59K

-11.11%-110K

-12.50%-108K

-Change in other working capital

-94.71%253K

-187.12%-230K

--52K

--232K

--199K

--4.79M

--264K

----

Cash from discontinued investing activities

Operating cash flow

-32.83%-103.76M

52.85%-14.15M

-111.44%-5.81M

49.51%-24.81M

-18.64%-59M

46.81%-78.11M

27.47%-30.01M

236.93%50.75M

-15.78%-49.13M

-91.38%-49.73M

Investing cash flow

Cash flow from continuing investing activities

175.61%174.65M

162.11%167.48M

119.88%13.46M

54.32%26.32M

-136.53%-32.61M

-279.93%-230.99M

-987.56%-269.64M

-176.14%-67.7M

-15.87%17.06M

897.71%89.29M

Net PPE purchase and sale

86.72%-288K

--0

211.54%29K

---317K

-868.30%-2.17M

-17,637.50%-1.42M

-1,665.85%-724K

82.55%-26K

--0

Net intangibles purchase and sale

-109.75%-3.5M

--0

---3.5M

1,296.67%35.9M

--0

-1,733.33%-55M

--90.9M

--0

Net investment purchase and sale

167.40%178.44M

162.44%167.48M

212.40%13.46M

135.62%26.29M

-132.25%-28.8M

-301.16%-264.73M

-982.65%-268.22M

-113.02%-11.98M

-461.44%-73.82M

899.57%89.29M

Cash from discontinued investing activities

Investing cash flow

175.61%174.65M

162.11%167.48M

119.88%13.46M

54.32%26.32M

-136.53%-32.61M

-279.93%-230.99M

-987.56%-269.64M

-176.14%-67.7M

-15.87%17.06M

897.71%89.29M

Financing cash flow

Cash flow from continuing financing activities

-99.40%1.22M

-74.55%471K

-42.33%748K

23.96%203.29M

210.05%1.85M

173,895.65%200.1M

-99.20%1.3M

-95.95%48K

Net common stock issuance

--0

----

10.39%178.18M

--0

--178.18M

----

Proceeds from stock option exercised by employees

-95.15%1.22M

-74.55%471K

--0

-42.33%748K

--0

870.40%25.11M

210.05%1.85M

18,959.13%21.92M

87.43%1.3M

-95.95%48K

Cash from discontinued financing activities

Financing cash flow

-99.40%1.22M

-74.55%471K

--0

-42.33%748K

--0

23.96%203.29M

210.05%1.85M

173,895.65%200.1M

-99.20%1.3M

-95.95%48K

Net cash flow

Beginning cash position

-45.85%124.97M

-89.76%43.28M

-85.13%35.62M

-87.66%33.36M

-45.85%124.97M

170.68%230.78M

75.29%422.77M

26.64%239.62M

448.82%270.39M

170.68%230.78M

Current changes in cash

168.15%72.11M

151.65%153.8M

-95.82%7.66M

107.36%2.26M

-331.30%-91.61M

-172.71%-105.82M

-2,764.81%-297.8M

252.43%183.15M

-121.99%-30.78M

210.04%39.61M

End cash Position

57.70%197.08M

-89.76%43.28M

-85.13%35.62M

-87.66%33.36M

-45.85%124.97M

75.29%422.77M

26.64%239.62M

448.82%270.39M

Free cash flow

29.40%-107.58M

54.98%-14.15M

-16.78%-5.81M

62.56%-24.81M

-26.31%-62.81M

-1.54%-152.38M

24.05%-31.43M

87.61%-4.97M

-55.60%-66.26M

-91.18%-49.73M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-32.83%-103.76M	52.85%-14.15M	-111.44%-5.81M	49.51%-24.81M	-18.64%-59M	46.81%-78.11M	27.47%-30.01M	236.93%50.75M	-15.78%-49.13M	-91.38%-49.73M
Net income from continuing operations	-12.38%-107.32M	67.62%-21.28M	-153.26%-19.73M	-588.04%-30.32M	42.33%-36M	49.45%-95.5M	-20.55%-65.71M	180.25%37.04M	90.39%-4.41M	-47.22%-62.41M
Operating gains losses	100.07%71K	--0	--0	----	----	---108M	--0	--0	----	----
Depreciation and amortization	86.59%3.79M	30.96%994K	25.20%934K	136.27%964K	670.69%894K	429.77%2.03M	636.89%759K	653.54%746K	343.48%408K	30.34%116K
Other non cash items	----	----	----	----	----	1,733.33%55M	--0	----	----	----
Change In working capital	-209.30%-28.94M	-106.43%-1.72M	114.46%7.55M	-104.46%-2.27M	-2,775.39%-32.51M	181.16%26.48M	603.37%26.74M	-5,254.56%-52.21M	5,872.13%50.74M	-83.74%1.22M
-Change in receivables	7.33%-12.86M	-93.75%-10.04M	573.92%2.97M	82.32%-1.62M	---4.18M	---13.88M	---5.18M	--441K	---9.14M	--0
-Change in inventory	11.81%-2.86M	237.86%772K	81.21%-480K	-2,179.07%-2.94M	---212K	---3.24M	---560K	---2.55M	---129K	--0
-Change in prepaid assets	153.15%2.37M	269.87%3.8M	-53.99%346K	72.34%-1.07M	-179.19%-700K	-45.52%-4.46M	-93.42%-2.23M	191.15%752K	-56.80%-3.87M	-35.85%884K
-Change in payables and accrued expense	-136.32%-15.54M	-87.06%4.36M	108.62%4.77M	-95.25%3.04M	-6,411.16%-27.71M	231.94%42.79M	565.37%33.68M	-120,139.13%-55.31M	3,696.85%63.98M	-92.91%439K
-Change in other current liabilities	-163.32%-309K	-149.28%-377K	-86.44%-110K	179.09%87K	184.26%91K	220.49%488K	821.70%765K	43.27%-59K	-11.11%-110K	-12.50%-108K
-Change in other working capital	-94.71%253K	-187.12%-230K	--52K	--232K	--199K	--4.79M	--264K	----	----	----
Cash from discontinued investing activities
Operating cash flow	-32.83%-103.76M	52.85%-14.15M	-111.44%-5.81M	49.51%-24.81M	-18.64%-59M	46.81%-78.11M	27.47%-30.01M	236.93%50.75M	-15.78%-49.13M	-91.38%-49.73M
Investing cash flow
Cash flow from continuing investing activities	175.61%174.65M	162.11%167.48M	119.88%13.46M	54.32%26.32M	-136.53%-32.61M	-279.93%-230.99M	-987.56%-269.64M	-176.14%-67.7M	-15.87%17.06M	897.71%89.29M
Net PPE purchase and sale	86.72%-288K	--0	--0	211.54%29K	---317K	-868.30%-2.17M	-17,637.50%-1.42M	-1,665.85%-724K	82.55%-26K	--0
Net intangibles purchase and sale	-109.75%-3.5M	--0	--0	--0	---3.5M	1,296.67%35.9M	--0	-1,733.33%-55M	--90.9M	--0
Net investment purchase and sale	167.40%178.44M	162.44%167.48M	212.40%13.46M	135.62%26.29M	-132.25%-28.8M	-301.16%-264.73M	-982.65%-268.22M	-113.02%-11.98M	-461.44%-73.82M	899.57%89.29M
Cash from discontinued investing activities
Investing cash flow	175.61%174.65M	162.11%167.48M	119.88%13.46M	54.32%26.32M	-136.53%-32.61M	-279.93%-230.99M	-987.56%-269.64M	-176.14%-67.7M	-15.87%17.06M	897.71%89.29M
Financing cash flow
Cash flow from continuing financing activities	-99.40%1.22M	-74.55%471K	0	-42.33%748K	0	23.96%203.29M	210.05%1.85M	173,895.65%200.1M	-99.20%1.3M	-95.95%48K
Net common stock issuance	--0	--0	----	----	----	10.39%178.18M	--0	--178.18M	----	----
Proceeds from stock option exercised by employees	-95.15%1.22M	-74.55%471K	--0	-42.33%748K	--0	870.40%25.11M	210.05%1.85M	18,959.13%21.92M	87.43%1.3M	-95.95%48K
Cash from discontinued financing activities
Financing cash flow	-99.40%1.22M	-74.55%471K	--0	-42.33%748K	--0	23.96%203.29M	210.05%1.85M	173,895.65%200.1M	-99.20%1.3M	-95.95%48K
Net cash flow
Beginning cash position	-45.85%124.97M	-89.76%43.28M	-85.13%35.62M	-87.66%33.36M	-45.85%124.97M	170.68%230.78M	75.29%422.77M	26.64%239.62M	448.82%270.39M	170.68%230.78M
Current changes in cash	168.15%72.11M	151.65%153.8M	-95.82%7.66M	107.36%2.26M	-331.30%-91.61M	-172.71%-105.82M	-2,764.81%-297.8M	252.43%183.15M	-121.99%-30.78M	210.04%39.61M
End cash Position	57.70%197.08M	57.70%197.08M	-89.76%43.28M	-85.13%35.62M	-87.66%33.36M	-45.85%124.97M	-45.85%124.97M	75.29%422.77M	26.64%239.62M	448.82%270.39M
Free cash flow	29.40%-107.58M	54.98%-14.15M	-16.78%-5.81M	62.56%-24.81M	-26.31%-62.81M	-1.54%-152.38M	24.05%-31.43M	87.61%-4.97M	-55.60%-66.26M	-91.18%-49.73M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm